FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA has approved Allergan's supplemental application for VIIBRYD (vilazodone hydrochloride), granting approval for the requested change to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Viibryd (vilazodone)

Snippet

SUPPL AP for VIIBRYD (VILAZODONE HYDROCHLORIDE)